• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Chronic prostatic inflammation: a confounding factor in the diagnosis of prostatic cancer].

作者信息

Rodríguez Rodríguez R, Mayayo Dehesa T, Galbis Sanjuan F, Burgos Revilla F J, Jiménez Cidre M, García González R

机构信息

Unidad de Ecografía Urológica, Madrid, España.

出版信息

Arch Esp Urol. 1996 Sep;49(7):669-73.

PMID:9020002
Abstract

OBJECTIVES

To evaluate the influence of inflammatory foci of the prostate on the efficacy of PSA and transrectal ultrasound in the diagnosis of prostatic cancer.

METHODS

Ultrasound-guided transrectal biopsy was performed in 399 patients. The results of serum PSA, PSA density and ultrasound characteristics were compared with the pathological findings.

RESULTS

The mean prostatic volume was greater in the cases with BPH and chronic inflammatory foci than those with prostatic cancer (p < 0.001). Twenty percent of the patients showed suspicious areas vs 75.1% of the cancers (< 0.001); 66.7% of those with chronic inflammatory foci showed classifications vs 40.6% of the cancers (p < 0.001). The patients with chronic inflammatory foci had PSA values that fell in between those of the BPH and cancer groups (p < 0.05). PSA density also showed intermediate values, although they were not significantly different.

CONCLUSIONS

The presence of chronic prostatic inflammatory foci can increase serum PSA levels. To date, it is not possible to identify this group of patients to avoid a biopsy.

摘要

相似文献

1
[Chronic prostatic inflammation: a confounding factor in the diagnosis of prostatic cancer].
Arch Esp Urol. 1996 Sep;49(7):669-73.
2
Detection of prostatic carcinoma: the role of TRUS, TRUS guided biopsy, digital rectal examination, PSA and PSA density.前列腺癌的检测:超声引导下经直肠超声检查(TRUS)、TRUS引导下活检、直肠指检、前列腺特异性抗原(PSA)及PSA密度的作用
J Exp Clin Cancer Res. 2001 Dec;20(4):473-80.
3
Ratio of free-to-total prostate specific antigen in serum cannot distinguish patients with prostate cancer from those with chronic inflammation of the prostate.血清中游离前列腺特异性抗原与总前列腺特异性抗原的比值无法区分前列腺癌患者和前列腺慢性炎症患者。
J Urol. 1998 May;159(5):1595-8. doi: 10.1097/00005392-199805000-00050.
4
Role of AgNOR count and its correlation with serum PSA levels in prostatic lesions.前列腺病变中核仁组成区嗜银蛋白计数的作用及其与血清前列腺特异抗原水平的相关性。
Urol Int. 2009;82(3):286-90. doi: 10.1159/000209359. Epub 2007 Apr 16.
5
Treatment of chronic prostatitis lowers serum prostate specific antigen.慢性前列腺炎的治疗可降低血清前列腺特异性抗原水平。
J Urol. 2002 Apr;167(4):1723-6.
6
Effects of antibacterial therapy on PSA change in the presence and absence of prostatic inflammation in patients with PSA levels between 4 and 10 ng/ml.
Prostate Cancer Prostatic Dis. 2006;9(3):235-8. doi: 10.1038/sj.pcan.4500885. Epub 2006 May 23.
7
[Clinical usefulness of free PSA/total PSA ratio in the early diagnosis of prostatic cancer].游离前列腺特异抗原与总前列腺特异抗原比值在前列腺癌早期诊断中的临床应用价值
Arch Esp Urol. 2000 May;53(4):333-41.
8
Serum PSA and percent free PSA value changes after antibiotic treatment. A diagnostic method in prostate cancer suspects with asymptomatic prostatitis.抗生素治疗后血清前列腺特异性抗原(PSA)及游离PSA百分比值的变化。一种针对疑似前列腺癌合并无症状前列腺炎患者的诊断方法。
Urol Int. 2008;80(2):186-92. doi: 10.1159/000112612. Epub 2008 Mar 19.
9
Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men.重复前列腺穿刺活检中前列腺癌的最佳预测指标:一项针对1051名男性的前瞻性研究
J Urol. 2000 Apr;163(4):1144-8; discussion 1148-9.
10
The issue of prostate cancer evaluation in men with elevated prostate-specific antigen and chronic prostatitis.前列腺特异性抗原升高且患有慢性前列腺炎的男性的前列腺癌评估问题。
Andrologia. 2008 Apr;40(2):130-3. doi: 10.1111/j.1439-0272.2007.00820.x.